scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-9149(87)91021-6 |
P698 | PubMed publication ID | 3661391 |
P50 | author | Jane A. Cauley | Q19668152 |
Lewis Kuller | Q88077314 | ||
P2093 | author name string | W S Dai | |
J P Gutai | |||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | coronary artery disease | Q844935 |
P304 | page(s) | 771-777 | |
P577 | publication date | 1987-10-01 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Usefulness of sex steroid hormone levels in predicting coronary artery disease in men | |
P478 | volume | 60 |
Q26822460 | A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events |
Q58248183 | Androgens and cardiovascular disease in men and women |
Q37084126 | Androgens and male aging: Current evidence of safety and efficacy |
Q50549102 | Assessment of possible effects for testosterone replacement therapy in men with symptomatic late-onset hypogonadism. |
Q89176771 | Association between sex hormones and ambulatory blood pressure |
Q37413949 | Association of serum testosterone with lipid abnormalities in patients with angiographically proven coronary artery disease |
Q58245091 | Canadian practice recommendations for screening, monitoring and treating men affected by andropause or partial androgen deficiency |
Q41664440 | Declining gonadal function in elderly men. |
Q44249460 | Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. |
Q77452765 | Drugs causing dyslipoproteinemia |
Q33916791 | Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort |
Q36735184 | Endogenous Estradiol and Testosterone may Predispose toward Atherogenic Lipid Profile, but Higher Blood Level of Testosterone is Associated with Lower Number of Stenoses in the Coronary Arteries of Men with Coronary Disease |
Q37339484 | Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. |
Q26828911 | Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study |
Q43744352 | Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis |
Q37219135 | Long-term stability of maternal prenatal steroid hormones from the National Collaborative Perinatal Project: still valid after all these years. |
Q80193527 | Low testosterone levels are associated with coronary artery disease in male patients with angina |
Q57398583 | Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years |
Q37988012 | Plasma testosterone is associated with Framingham risk score |
Q89927740 | Polychlorinated Biphenyls (PCBs) and Sex Hormone Concentrations in Ringed and Grey Seals: A Possible Link to Endocrine Disruption? |
Q45166336 | Progetto ATENA, a study on the etiology of major chronic diseases in women: design, rationale and objectives |
Q31881777 | Psychophysiological responses to the Stroop Task after a maximal cycle ergometry in elite sportsmen and physically active subjects |
Q28602465 | Reactive oxygen species: players in the cardiovascular effects of testosterone |
Q46701075 | Relationship between androgenic hormones and arterial stiffness, based on longitudinal hormone measurements |
Q38099508 | Risks and benefits of testosterone therapy in older men. |
Q37639200 | Sex steroids and cardiovascular disease |
Q44844505 | Sex steroids and heart rate variability in patients after myocardial infarction. |
Q33937824 | Sodium-induced rise in blood pressure is suppressed by androgen receptor blockade |
Q50913294 | Steroid sex hormones and peripheral arterial disease in the Edinburgh Artery Study. |
Q37376009 | Testosterone and ill-health in aging men. |
Q27000507 | Testosterone and the cardiovascular system: a comprehensive review of the clinical literature |
Q35546614 | Testosterone replacement and cardiovascular safety: no straight and narrow! |
Q35589227 | Testosterone supplementation: why and for whom? |
Q33682432 | Testosterone, dihydrotestosterone, and incident cardiovascular disease and mortality in the cardiovascular health study |
Q24658011 | The benefits and risks of testosterone replacement therapy: a review |
Q54101741 | The effect of ketoconazole and transdermal estradiol on serum sex steroid hormones levels. |
Q34938339 | The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures |
Q50959775 | Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: a nested case-referent study in the DOM-cohort. |
Q38551472 | Usual consumption of plant foods containing phytoestrogens and sex hormone levels in postmenopausal women in Wisconsin |
Search more.